Age, Pneumonectomy Linked to Poor NSCLC Surgery Outcomes
July 9th 2024This new analysis incorporated 1997-2013 data on patients with a history of surgical resection of stage IIIA-N2 non-small cell lung cancer (NSCLC) and their postop complications to evaluate the possibility of better identifying future surgical candidates.
Read More
BLU-222 Shows Safety, Tolerability in Combination Therapy for Patients With Breast Cancer
July 9th 2024Early data suggest that BLU-222 combined with ribociclib and fulvestrant is safe and tolerable for patients with HR-positive and HER2-negative breast cancer, potentially overcoming resistance to CDK4/6 inhibitors.
Read More
Dr Mark Bleackley: New Medication to Benefit Patients With Obstructive Sleep Apnea
July 9th 2024Mark Bleackley, PhD, chief scientific officer, Incannex, details the progress of the ongoing RePOSA trial, which is assessing the safety and efficacy of IHL-42X in patients with obstructive sleep apnea (OSA).
Read More
Five Children, 2 Hearing-Improved Ears Each: Successful DFNB9 Gene Therapy
July 8th 2024The interim results of a single-arm trial in children with autosomal recessive deafness 9 (DFNB9) show the benefits of binaural administration of gene therapy: better hearing with no serious adverse effects.
Read More
Timothy Caulfield Previews SPD 2024 Session on Misinformation in Pediatric Dermatology
July 8th 2024Timothy Caulfield, JD, discusses the sessions he's most looking forward to at this year's Society for Pediatric Dermatology annual meeting, including his talk on overcoming misinformation in pediatric dermatology.
Watch
Certain Low-Prevalence Mutations May Be Strong Drivers in Pediatric ALL
July 4th 2024The researchers noted that most genomic analyses have traditionally focused on commonly mutated genes, which can pinpoint mutations occurring most frequently but does not account for the extent to which these mutations impact cancer cell survival and proliferation.
Read More